カテゴリ： 世界, 医療/バイオ, QYResearch

生物工学による代用皮膚の世界市場2023年：同種無細胞、異種、同種細胞、自家細胞

■ 英語タイトル：Global Bioengineered Skin Substitutes Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7427）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7427
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：112
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[生物工学による代用皮膚の世界市場2023年：同種無細胞、異種、同種細胞、自家細胞]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は生物工学による代用皮膚のグローバル市場について調査・分析し、世界の生物工学による代用皮膚市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（同種無細胞、異種、同種細胞、自家細胞）、用途別セグメント分析（病院、専門クリニック、創傷治療センター）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Allergan (AbbVie)、AlloSource、Organogenesis、BD、Smith & Nephew、Integra LifeSciences、Synthes (Johnson & Johnson)、Axogen、Vericel Corporation、LifeNet Health、MTF Biologics、Arthrex、Wright Medical Group NV (Stryker)、Cook Biotech Incorporated、Aroa Biosurgery、Surgalign Holdings、Anika Therapeutics、Forticell Bioscience、MLM Biologics、Promethean LifeSciencesなどが含まれています。生物工学による代用皮膚のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、生物工学による代用皮膚市場規模を算出する際に考慮しました。

・生物工学による代用皮膚市場の概要
- 生物工学による代用皮膚の種類別セグメント
- 世界の生物工学による代用皮膚市場規模：タイプ別分析（同種無細胞、異種、同種細胞、自家細胞）
- 生物工学による代用皮膚の用途別セグメント
- 世界の生物工学による代用皮膚市場規模：用途別分析（病院、専門クリニック、創傷治療センター）
- 世界の生物工学による代用皮膚市場規模予測（2018年-2029年）

・生物工学による代用皮膚市場の成長トレンド
- 生物工学による代用皮膚の地域別市場規模（2018年-2029年）
- 生物工学による代用皮膚市場ダイナミクス
- 生物工学による代用皮膚の業界動向
- 生物工学による代用皮膚市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：同種無細胞、異種、同種細胞、自家細胞
- 世界の生物工学による代用皮膚のタイプ別市場規模（2018年-2023年）
- 世界の生物工学による代用皮膚のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、専門クリニック、創傷治療センター
- 世界の生物工学による代用皮膚の用途別市場規模（2018年-2023年）
- 世界の生物工学による代用皮膚の用途別市場規模（2024年-2029年）

・生物工学による代用皮膚の地域別市場規模
- 北米の生物工学による代用皮膚市場規模（2018年-2029年）
- 米国の生物工学による代用皮膚市場規模（2018年-2029年）
- ヨーロッパの生物工学による代用皮膚市場規模（2018年-2029年）
- アジア太平洋の生物工学による代用皮膚市場規模（2018年-2029年）
- 中国の生物工学による代用皮膚市場規模（2018年-2029年）
- 日本の生物工学による代用皮膚市場規模（2018年-2029年）
- 韓国の生物工学による代用皮膚市場規模（2018年-2029年）
- インドの生物工学による代用皮膚市場規模（2018年-2029年）
- オーストラリアの生物工学による代用皮膚市場規模（2018年-2029年）
- 中南米の生物工学による代用皮膚市場規模（2018年-2029年）
- 中東・アフリカの生物工学による代用皮膚市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Allergan (AbbVie)、AlloSource、Organogenesis、BD、Smith & Nephew、Integra LifeSciences、Synthes (Johnson & Johnson)、Axogen、Vericel Corporation、LifeNet Health、MTF Biologics、Arthrex、Wright Medical Group NV (Stryker)、Cook Biotech Incorporated、Aroa Biosurgery、Surgalign Holdings、Anika Therapeutics、Forticell Bioscience、MLM Biologics、Promethean LifeSciences

・アナリストの観点/結論

・調査手法と情報源

Bioengineered skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
Highlights
The global Bioengineered Skin Substitutes market was valued at US$ 1717.4 million in 2022 and is anticipated to reach US$ 3355.4 million by 2029, witnessing a CAGR of 11.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global important companies in bioengineered skin substitutes includes Allergan (AbbVie), AlloSource, Organogenesis, and BD. The head company shares over 30% of the market. Geographically speaking, Americas holds about 50% of global market share, followed by Europe with about 35% share. Bioengineered skin substitutes includes Allogeneic Acellular, Xenogeneic, Allogeneic Cells, and Autologous. Allogeneic Acellular is the largest part of bioengineered skin substitutes industry, has a share about 80%. Other key parts include Xenogeneic who shares nearly 15% , and Autologous who shares about 5%. The application of bioengineered skin substitutes includes hospitals,specialty clinics and wound care centers. Hospitals shares the largest percent of 60.30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioengineered Skin Substitutes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioengineered Skin Substitutes.
The Bioengineered Skin Substitutes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bioengineered Skin Substitutes market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioengineered Skin Substitutes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Allergan (AbbVie)
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Wright Medical Group NV (Stryker)
Cook Biotech Incorporated
Aroa Biosurgery
Surgalign Holdings
Anika Therapeutics
Forticell Bioscience
MLM Biologics
Promethean LifeSciences
Segment by Type
Allogeneic Acellular
Xenogeneic
Allogeneic Cells
Autologous
Segment by Application
Hospitals
Specialty Clinics
Wound Care Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioengineered Skin Substitutes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bioengineered Skin Substitutes Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Allogeneic Acellular
1.2.3 Xenogeneic
1.2.4 Allogeneic Cells
1.2.5 Autologous
1.3 Market by Application
1.3.1 Global Bioengineered Skin Substitutes Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Wound Care Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioengineered Skin Substitutes Market Perspective (2018-2029)
2.2 Bioengineered Skin Substitutes Growth Trends by Region
2.2.1 Global Bioengineered Skin Substitutes Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bioengineered Skin Substitutes Historic Market Size by Region (2018-2023)
2.2.3 Bioengineered Skin Substitutes Forecasted Market Size by Region (2024-2029)
2.3 Bioengineered Skin Substitutes Market Dynamics
2.3.1 Bioengineered Skin Substitutes Industry Trends
2.3.2 Bioengineered Skin Substitutes Market Drivers
2.3.3 Bioengineered Skin Substitutes Market Challenges
2.3.4 Bioengineered Skin Substitutes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioengineered Skin Substitutes Players by Revenue
3.1.1 Global Top Bioengineered Skin Substitutes Players by Revenue (2018-2023)
3.1.2 Global Bioengineered Skin Substitutes Revenue Market Share by Players (2018-2023)
3.2 Global Bioengineered Skin Substitutes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bioengineered Skin Substitutes Revenue
3.4 Global Bioengineered Skin Substitutes Market Concentration Ratio
3.4.1 Global Bioengineered Skin Substitutes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioengineered Skin Substitutes Revenue in 2022
3.5 Bioengineered Skin Substitutes Key Players Head office and Area Served
3.6 Key Players Bioengineered Skin Substitutes Product Solution and Service
3.7 Date of Enter into Bioengineered Skin Substitutes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioengineered Skin Substitutes Breakdown Data by Type
4.1 Global Bioengineered Skin Substitutes Historic Market Size by Type (2018-2023)
4.2 Global Bioengineered Skin Substitutes Forecasted Market Size by Type (2024-2029)
5 Bioengineered Skin Substitutes Breakdown Data by Application
5.1 Global Bioengineered Skin Substitutes Historic Market Size by Application (2018-2023)
5.2 Global Bioengineered Skin Substitutes Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Bioengineered Skin Substitutes Market Size (2018-2029)
6.2 North America Bioengineered Skin Substitutes Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bioengineered Skin Substitutes Market Size by Country (2018-2023)
6.4 North America Bioengineered Skin Substitutes Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioengineered Skin Substitutes Market Size (2018-2029)
7.2 Europe Bioengineered Skin Substitutes Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bioengineered Skin Substitutes Market Size by Country (2018-2023)
7.4 Europe Bioengineered Skin Substitutes Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioengineered Skin Substitutes Market Size (2018-2029)
8.2 Asia-Pacific Bioengineered Skin Substitutes Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (2018-2023)
8.4 Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioengineered Skin Substitutes Market Size (2018-2029)
9.2 Latin America Bioengineered Skin Substitutes Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bioengineered Skin Substitutes Market Size by Country (2018-2023)
9.4 Latin America Bioengineered Skin Substitutes Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioengineered Skin Substitutes Market Size (2018-2029)
10.2 Middle East & Africa Bioengineered Skin Substitutes Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (2018-2023)
10.4 Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan (AbbVie)
11.1.1 Allergan (AbbVie) Company Detail
11.1.2 Allergan (AbbVie) Business Overview
11.1.3 Allergan (AbbVie) Bioengineered Skin Substitutes Introduction
11.1.4 Allergan (AbbVie) Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.1.5 Allergan (AbbVie) Recent Development
11.2 AlloSource
11.2.1 AlloSource Company Detail
11.2.2 AlloSource Business Overview
11.2.3 AlloSource Bioengineered Skin Substitutes Introduction
11.2.4 AlloSource Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.2.5 AlloSource Recent Development
11.3 Organogenesis
11.3.1 Organogenesis Company Detail
11.3.2 Organogenesis Business Overview
11.3.3 Organogenesis Bioengineered Skin Substitutes Introduction
11.3.4 Organogenesis Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.3.5 Organogenesis Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Bioengineered Skin Substitutes Introduction
11.4.4 BD Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.4.5 BD Recent Development
11.5 Smith & Nephew
11.5.1 Smith & Nephew Company Detail
11.5.2 Smith & Nephew Business Overview
11.5.3 Smith & Nephew Bioengineered Skin Substitutes Introduction
11.5.4 Smith & Nephew Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.5.5 Smith & Nephew Recent Development
11.6 Integra LifeSciences
11.6.1 Integra LifeSciences Company Detail
11.6.2 Integra LifeSciences Business Overview
11.6.3 Integra LifeSciences Bioengineered Skin Substitutes Introduction
11.6.4 Integra LifeSciences Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.6.5 Integra LifeSciences Recent Development
11.7 Synthes (Johnson & Johnson)
11.7.1 Synthes (Johnson & Johnson) Company Detail
11.7.2 Synthes (Johnson & Johnson) Business Overview
11.7.3 Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Introduction
11.7.4 Synthes (Johnson & Johnson) Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.7.5 Synthes (Johnson & Johnson) Recent Development
11.8 Axogen
11.8.1 Axogen Company Detail
11.8.2 Axogen Business Overview
11.8.3 Axogen Bioengineered Skin Substitutes Introduction
11.8.4 Axogen Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.8.5 Axogen Recent Development
11.9 Vericel Corporation
11.9.1 Vericel Corporation Company Detail
11.9.2 Vericel Corporation Business Overview
11.9.3 Vericel Corporation Bioengineered Skin Substitutes Introduction
11.9.4 Vericel Corporation Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.9.5 Vericel Corporation Recent Development
11.10 LifeNet Health
11.10.1 LifeNet Health Company Detail
11.10.2 LifeNet Health Business Overview
11.10.3 LifeNet Health Bioengineered Skin Substitutes Introduction
11.10.4 LifeNet Health Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.10.5 LifeNet Health Recent Development
11.11 MTF Biologics
11.11.1 MTF Biologics Company Detail
11.11.2 MTF Biologics Business Overview
11.11.3 MTF Biologics Bioengineered Skin Substitutes Introduction
11.11.4 MTF Biologics Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.11.5 MTF Biologics Recent Development
11.12 Arthrex
11.12.1 Arthrex Company Detail
11.12.2 Arthrex Business Overview
11.12.3 Arthrex Bioengineered Skin Substitutes Introduction
11.12.4 Arthrex Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.12.5 Arthrex Recent Development
11.13 Wright Medical Group NV (Stryker)
11.13.1 Wright Medical Group NV (Stryker) Company Detail
11.13.2 Wright Medical Group NV (Stryker) Business Overview
11.13.3 Wright Medical Group NV (Stryker) Bioengineered Skin Substitutes Introduction
11.13.4 Wright Medical Group NV (Stryker) Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.13.5 Wright Medical Group NV (Stryker) Recent Development
11.14 Cook Biotech Incorporated
11.14.1 Cook Biotech Incorporated Company Detail
11.14.2 Cook Biotech Incorporated Business Overview
11.14.3 Cook Biotech Incorporated Bioengineered Skin Substitutes Introduction
11.14.4 Cook Biotech Incorporated Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.14.5 Cook Biotech Incorporated Recent Development
11.15 Aroa Biosurgery
11.15.1 Aroa Biosurgery Company Detail
11.15.2 Aroa Biosurgery Business Overview
11.15.3 Aroa Biosurgery Bioengineered Skin Substitutes Introduction
11.15.4 Aroa Biosurgery Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.15.5 Aroa Biosurgery Recent Development
11.16 Surgalign Holdings
11.16.1 Surgalign Holdings Company Detail
11.16.2 Surgalign Holdings Business Overview
11.16.3 Surgalign Holdings Bioengineered Skin Substitutes Introduction
11.16.4 Surgalign Holdings Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.16.5 Surgalign Holdings Recent Development
11.17 Anika Therapeutics
11.17.1 Anika Therapeutics Company Detail
11.17.2 Anika Therapeutics Business Overview
11.17.3 Anika Therapeutics Bioengineered Skin Substitutes Introduction
11.17.4 Anika Therapeutics Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.17.5 Anika Therapeutics Recent Development
11.18 Forticell Bioscience
11.18.1 Forticell Bioscience Company Detail
11.18.2 Forticell Bioscience Business Overview
11.18.3 Forticell Bioscience Bioengineered Skin Substitutes Introduction
11.18.4 Forticell Bioscience Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.18.5 Forticell Bioscience Recent Development
11.19 MLM Biologics
11.19.1 MLM Biologics Company Detail
11.19.2 MLM Biologics Business Overview
11.19.3 MLM Biologics Bioengineered Skin Substitutes Introduction
11.19.4 MLM Biologics Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.19.5 MLM Biologics Recent Development
11.20 Promethean LifeSciences
11.20.1 Promethean LifeSciences Company Detail
11.20.2 Promethean LifeSciences Business Overview
11.20.3 Promethean LifeSciences Bioengineered Skin Substitutes Introduction
11.20.4 Promethean LifeSciences Revenue in Bioengineered Skin Substitutes Business (2018-2023)
11.20.5 Promethean LifeSciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bioengineered Skin Substitutes Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Allogeneic Acellular
Table 3. Key Players of Xenogeneic
Table 4. Key Players of Allogeneic Cells
Table 5. Key Players of Autologous
Table 6. Global Bioengineered Skin Substitutes Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Bioengineered Skin Substitutes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Bioengineered Skin Substitutes Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Bioengineered Skin Substitutes Market Share by Region (2018-2023)
Table 10. Global Bioengineered Skin Substitutes Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Bioengineered Skin Substitutes Market Share by Region (2024-2029)
Table 12. Bioengineered Skin Substitutes Market Trends
Table 13. Bioengineered Skin Substitutes Market Drivers
Table 14. Bioengineered Skin Substitutes Market Challenges
Table 15. Bioengineered Skin Substitutes Market Restraints
Table 16. Global Bioengineered Skin Substitutes Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Bioengineered Skin Substitutes Market Share by Players (2018-2023)
Table 18. Global Top Bioengineered Skin Substitutes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioengineered Skin Substitutes as of 2022)
Table 19. Ranking of Global Top Bioengineered Skin Substitutes Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Bioengineered Skin Substitutes Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bioengineered Skin Substitutes Product Solution and Service
Table 23. Date of Enter into Bioengineered Skin Substitutes Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bioengineered Skin Substitutes Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Bioengineered Skin Substitutes Revenue Market Share by Type (2018-2023)
Table 27. Global Bioengineered Skin Substitutes Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Bioengineered Skin Substitutes Revenue Market Share by Type (2024-2029)
Table 29. Global Bioengineered Skin Substitutes Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Bioengineered Skin Substitutes Revenue Market Share by Application (2018-2023)
Table 31. Global Bioengineered Skin Substitutes Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Bioengineered Skin Substitutes Revenue Market Share by Application (2024-2029)
Table 33. North America Bioengineered Skin Substitutes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Bioengineered Skin Substitutes Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Bioengineered Skin Substitutes Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Bioengineered Skin Substitutes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Bioengineered Skin Substitutes Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Bioengineered Skin Substitutes Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Bioengineered Skin Substitutes Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Bioengineered Skin Substitutes Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Bioengineered Skin Substitutes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Bioengineered Skin Substitutes Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Bioengineered Skin Substitutes Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Bioengineered Skin Substitutes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Bioengineered Skin Substitutes Market Size by Country (2024-2029) & (US$ Million)
Table 48. Allergan (AbbVie) Company Detail
Table 49. Allergan (AbbVie) Business Overview
Table 50. Allergan (AbbVie) Bioengineered Skin Substitutes Product
Table 51. Allergan (AbbVie) Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 52. Allergan (AbbVie) Recent Development
Table 53. AlloSource Company Detail
Table 54. AlloSource Business Overview
Table 55. AlloSource Bioengineered Skin Substitutes Product
Table 56. AlloSource Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 57. AlloSource Recent Development
Table 58. Organogenesis Company Detail
Table 59. Organogenesis Business Overview
Table 60. Organogenesis Bioengineered Skin Substitutes Product
Table 61. Organogenesis Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 62. Organogenesis Recent Development
Table 63. BD Company Detail
Table 64. BD Business Overview
Table 65. BD Bioengineered Skin Substitutes Product
Table 66. BD Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 67. BD Recent Development
Table 68. Smith & Nephew Company Detail
Table 69. Smith & Nephew Business Overview
Table 70. Smith & Nephew Bioengineered Skin Substitutes Product
Table 71. Smith & Nephew Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 72. Smith & Nephew Recent Development
Table 73. Integra LifeSciences Company Detail
Table 74. Integra LifeSciences Business Overview
Table 75. Integra LifeSciences Bioengineered Skin Substitutes Product
Table 76. Integra LifeSciences Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 77. Integra LifeSciences Recent Development
Table 78. Synthes (Johnson & Johnson) Company Detail
Table 79. Synthes (Johnson & Johnson) Business Overview
Table 80. Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Product
Table 81. Synthes (Johnson & Johnson) Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 82. Synthes (Johnson & Johnson) Recent Development
Table 83. Axogen Company Detail
Table 84. Axogen Business Overview
Table 85. Axogen Bioengineered Skin Substitutes Product
Table 86. Axogen Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 87. Axogen Recent Development
Table 88. Vericel Corporation Company Detail
Table 89. Vericel Corporation Business Overview
Table 90. Vericel Corporation Bioengineered Skin Substitutes Product
Table 91. Vericel Corporation Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 92. Vericel Corporation Recent Development
Table 93. LifeNet Health Company Detail
Table 94. LifeNet Health Business Overview
Table 95. LifeNet Health Bioengineered Skin Substitutes Product
Table 96. LifeNet Health Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 97. LifeNet Health Recent Development
Table 98. MTF Biologics Company Detail
Table 99. MTF Biologics Business Overview
Table 100. MTF Biologics Bioengineered Skin Substitutes Product
Table 101. MTF Biologics Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 102. MTF Biologics Recent Development
Table 103. Arthrex Company Detail
Table 104. Arthrex Business Overview
Table 105. Arthrex Bioengineered Skin Substitutes Product
Table 106. Arthrex Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 107. Arthrex Recent Development
Table 108. Wright Medical Group NV (Stryker) Company Detail
Table 109. Wright Medical Group NV (Stryker) Business Overview
Table 110. Wright Medical Group NV (Stryker) Bioengineered Skin Substitutes Product
Table 111. Wright Medical Group NV (Stryker) Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 112. Wright Medical Group NV (Stryker) Recent Development
Table 113. Cook Biotech Incorporated Company Detail
Table 114. Cook Biotech Incorporated Business Overview
Table 115. Cook Biotech Incorporated Bioengineered Skin Substitutes Product
Table 116. Cook Biotech Incorporated Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 117. Cook Biotech Incorporated Recent Development
Table 118. Aroa Biosurgery Company Detail
Table 119. Aroa Biosurgery Business Overview
Table 120. Aroa Biosurgery Bioengineered Skin Substitutes Product
Table 121. Aroa Biosurgery Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 122. Aroa Biosurgery Recent Development
Table 123. Surgalign Holdings Company Detail
Table 124. Surgalign Holdings Business Overview
Table 125. Surgalign Holdings Bioengineered Skin Substitutes Product
Table 126. Surgalign Holdings Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 127. Surgalign Holdings Recent Development
Table 128. Anika Therapeutics Company Detail
Table 129. Anika Therapeutics Business Overview
Table 130. Anika Therapeutics Bioengineered Skin Substitutes Product
Table 131. Anika Therapeutics Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 132. Anika Therapeutics Recent Development
Table 133. Forticell Bioscience Company Detail
Table 134. Forticell Bioscience Business Overview
Table 135. Forticell Bioscience Bioengineered Skin Substitutes Product
Table 136. Forticell Bioscience Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 137. Forticell Bioscience Recent Development
Table 138. MLM Biologics Company Detail
Table 139. MLM Biologics Business Overview
Table 140. MLM Biologics Bioengineered Skin Substitutes Product
Table 141. MLM Biologics Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 142. MLM Biologics Recent Development
Table 143. Promethean LifeSciences Company Detail
Table 144. Promethean LifeSciences Business Overview
Table 145. Promethean LifeSciences Bioengineered Skin Substitutes Product
Table 146. Promethean LifeSciences Revenue in Bioengineered Skin Substitutes Business (2018-2023) & (US$ Million)
Table 147. Promethean LifeSciences Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bioengineered Skin Substitutes Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Bioengineered Skin Substitutes Market Share by Type: 2022 VS 2029
Figure 3. Allogeneic Acellular Features
Figure 4. Xenogeneic Features
Figure 5. Allogeneic Cells Features
Figure 6. Autologous Features
Figure 7. Global Bioengineered Skin Substitutes Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Bioengineered Skin Substitutes Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Wound Care Centers Case Studies
Figure 12. Bioengineered Skin Substitutes Report Years Considered
Figure 13. Global Bioengineered Skin Substitutes Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Bioengineered Skin Substitutes Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Bioengineered Skin Substitutes Market Share by Region: 2022 VS 2029
Figure 16. Global Bioengineered Skin Substitutes Market Share by Players in 2022
Figure 17. Global Top Bioengineered Skin Substitutes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioengineered Skin Substitutes as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Bioengineered Skin Substitutes Revenue in 2022
Figure 19. North America Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Bioengineered Skin Substitutes Market Share by Country (2018-2029)
Figure 21. United States Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Bioengineered Skin Substitutes Market Share by Country (2018-2029)
Figure 25. Germany Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Bioengineered Skin Substitutes Market Share by Region (2018-2029)
Figure 33. China Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Bioengineered Skin Substitutes Market Share by Country (2018-2029)
Figure 41. Mexico Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Bioengineered Skin Substitutes Market Share by Country (2018-2029)
Figure 45. Turkey Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Bioengineered Skin Substitutes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Allergan (AbbVie) Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 48. AlloSource Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 49. Organogenesis Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 50. BD Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 51. Smith & Nephew Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 52. Integra LifeSciences Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 53. Synthes (Johnson & Johnson) Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 54. Axogen Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 55. Vericel Corporation Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 56. LifeNet Health Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 57. MTF Biologics Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 58. Arthrex Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 59. Wright Medical Group NV (Stryker) Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 60. Cook Biotech Incorporated Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 61. Aroa Biosurgery Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 62. Surgalign Holdings Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 63. Anika Therapeutics Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 64. Forticell Bioscience Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 65. MLM Biologics Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 66. Promethean LifeSciences Revenue Growth Rate in Bioengineered Skin Substitutes Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 脳震盪の世界市場2023年：治療、診断
  • 人工皮膚マトリックスの世界市場2023年：動物由来、ヒト由来
  • 細胞培養プロセス開発の世界市場2023年：上流工程開発、下流工程開発
  • パーソナルケア用デリバリーシステムの世界市場2023年：リポソーム、マイクロカプセル化、その他
  • KNX認定製品の世界市場2023年：エネルギー管理、HVACシステム、ブラインド＆シャッター、メーター、リモコン、監視システム、火災＆煙検出、白物家電、照明
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7427 )"生物工学による代用皮膚の世界市場2023年：同種無細胞、異種、同種細胞、自家細胞" (英文：Global Bioengineered Skin Substitutes Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。